Molina Healthcare schedules October 21 results. Molina Healthcare stock gains 5.27 percent

Published on 10/20/2026 at 21:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue fell 4.80 percent in second quarter 2026. Molina Healthcare stock traded at EUR 196.43 on October 20, 2026, up 5.27 percent on NYSE.

Reporting date October 21, 2026

Molina Healthcare scheduled its third-quarter 2026 results for October 21, 2026.
Second-quarter revenue reached USD 10.87 billion after a 4.80 percent year-over-year decline.
Molina Healthcare stock traded at EUR 196.43 at Lang & Schwarz on October 20, 2026 at 9:16 p.m. CEST, up 5.27 percent on NYSE.

Isometrische Illustration einer Gesundheitsversorgungskette mit Klinik, Apotheke und Datenanalyse — Isometrische 3D-Grafik erklärt Molina Healthcare US60855R1005 anhand der Wertschöpfungskette im Gesundheitswesen von Klinik bis Apotheke, Illustration mit AI erstellt.

Molina Healthcare has scheduled its third-quarter 2026 results for October 21, 2026, giving investors a near-term test after a weaker second quarter. MarketBeat reports that the release is expected after the market close. At Lang & Schwarz, the stock was trading at EUR 196.43 on October 20, 2026 at 9:16 p.m. CEST, while the NYSE quote was up 5.27 percent on the day.

Second-quarter revenue sets the hurdle

Molina Healthcare reported USD 10.87 billion in revenue for the second quarter of 2026, down 4.80 percent from the same quarter a year earlier. Net income attributable to common shareholders was USD 60.00 million, while diluted earnings per share reached USD 1.19. Markets Insider also reported quarterly revenue of USD 10.87 billion and net profit of USD 60.00 million for the period ended June 30, 2026.

The coming report therefore has two measurable comparisons. Analysts expect third-quarter revenue of USD 10.86 billion and earnings of USD 0.79 per share, versus USD 11.48 billion and USD 1.84 per share in the year-earlier quarter, according to MarketBeat.

What does the price position show?

The NYSE quote stood at USD 221.27 on October 20, 2026 at 3:20 p.m. ET. Molina Healthcare's 52-week range was USD 121.06 to USD 244.89, placing the price USD 23.62 below the high and USD 100.21 above the low. Trading volume was 565,037 shares, compared with an average volume of 885,401 shares.

Valuation and reporting dates

The market capitalization was USD 11.6 billion on October 20, 2026. The reported price-to-earnings ratio was 1,163.11, reflecting the company's very low trailing earnings base. The next two scheduled dates are October 21, 2026 for the third-quarter results and October 22, 2026 at 8:00 a.m. ET for the earnings call, as listed by MarketBeat.

Comparison with peers

Molina Healthcare: up 5.27 percent on NYSE, P/E 1,163.11, market capitalization USD 11.6 billion as of October 20, 2026.

Elevance Health (NYSE, USD): up 1.91 percent, P/E 19.49, market capitalization USD 95.1 billion as of October 20, 2026.

UnitedHealth Group (NYSE, USD): up 3.12 percent, P/E 23.95, market capitalization USD 376.6 billion as of October 20, 2026.

The earnings test is next

The upcoming figures will put the second-quarter revenue decline beside the current consensus for lower earnings and revenue. Molina Healthcare was trading at EUR 196.43 at Lang & Schwarz on October 20, 2026 at 9:16 p.m. CEST, with the NYSE quote up 5.27 percent on the day. The further course of trading is shown by the continuously updated real-time quote of Molina Healthcare stock.